The European Commission President Ursula von der Leyen revealed that the vaccines from the drugmaker of the U.S. and its German partner BioNTech would be successfully delivered over the period from 2021 to 2023. This news is published after his visit to vaccine plant of Pfizer in Puurs, Belgium.
The latest agreements
The European Commission wants to seal the largest vaccine deliver deal in the world within days and buy up to 1.8 billion quantity of Covid-19 vaccine of Pfizer for the next three years mainly as a debate rages over the complete unfair access to shots for the poorest people of the world. This agreement would be sufficient for inoculating the 450 million European population for 2 years and the long-term supplies. This is the 3rd contract signed by the bloc with the 2 companies which agreed to supply 600 million doses of the 2-dose vaccine this year as per the 2 previous contracts.
Brussels has an aim to inoculate at least seventy percentages of the European adults within July. This move is because of the Commission looks at sever ties with the popular AstraZeneca subsequent to the drugmaker slashed its delivery targets because of the production problems. The commission was deciding whether to take any legal action in opposition to the British-Swedish pharmaceutical company. Though the supply deal was agreed in principle, there was a requirement at both sides to iron out final terms.
Vaccines for everyone
The overall efforts of the Commission will secure the essential doses to give booster shots for increasing immunity. Pfizer has successfully scrambled to maximize the output in recent months because it’s Belgian and U.S. plants have to meet growing demand. The European drug regulator revealed that it had approved an increase in the overall batch sizes for shots made and ensured a 20% increase in output.